Cite
HARVARD Citation
Halalsheh, H. et al. (2018). Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma. Pediatric blood & cancer. 65 (10), p. n/a. [Online].